Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Percentage of Participants Achieving 28 Days Seizure Free Period in Intent-to Treat (ITT) Population |
Participants were regarded as seizure-free if no seizures (partial or other) were reported for the participant during the period of 28 days in the study. |
Baseline through Week 12 |
|
Primary |
Percentage of Participants Achieving 28 Days Seizure Free Period in Per Protocol (PP) Population |
Participants were regarded as seizure-free if no seizures (partial or other) were reported for the participant during the period of 28 days in the study. |
Baseline through Week 12 |
|
Primary |
Percentage of Participants With Improvement in Seizure Frequency in ITT Population |
Percentage of participants with improvement in seizure frequency of greater than or equal to 75%; greater than or equal to 50% to 74%; 0% to 49% were considered. |
Baseline through Week 12 |
|
Primary |
Percentage of Participants With Improvement in Seizure Frequency in PP Population |
Percentage of participants with improvement in seizure frequency of greater than or equal to 75%; greater than or equal to 50% to 74%; 0% to 49% were considered. |
Baseline through Week 12 |
|
Primary |
Change From Baseline in Daily Pain Score for NeP in ITT Population at Week 6 |
Daily Pain Rating Score (DPRS): participant rated 11-point Likert scale ranging from 0 (no pain) to 10 (worst possible pain) during past 24-hour period. Higher score indicates greater level of pain. |
Baseline and Week 6 |
|
Primary |
Change From Baseline in Daily Pain Score for NeP in PP Population at Week 6 |
DPRS: participant rated 11-point Likert scale ranging from 0 (no pain) to 10 (worst possible pain) during past 24-hour period. Higher score indicates greater level of pain. |
Baseline and Week 6 |
|
Primary |
Change From Baseline in Daily Pain Score for Fibromyalgia in ITT Population at Week 6 |
DPRS: participant rated 11-point Likert scale ranging from 0 (no pain) to 10 (worst possible pain) during past 24-hour period. Higher score indicates greater level of pain. |
Baseline and Week 6 |
|
Primary |
Change From Baseline in Daily Pain Score for Fibromyalgia in PP Population at Week 6 |
DPRS: participant rated 11-point Likert scale ranging from 0 (no pain) to 10 (worst possible pain) during past 24-hour period. Higher score indicates greater level of pain. |
Baseline and Week 6 |
|
Secondary |
Change From Baseline in Sleep Interference Score for NeP in ITT Population at Week 6 |
Daily Sleep Interference Score (DSIS): participant rated 11-point Likert scale ranging from 0 (pain does not interfere with sleep) to 10 (pain completely interferes with sleep) during past 24-hour period. Higher score indicates a greater level of sleep disturbance. Self-assessment performed daily on awakening prior to taking study medication. |
Baseline and Week 6 |
|
Secondary |
Change From Baseline in Sleep Interference Score for NeP in PP Population at Week 6 |
DSIS: participant rated 11-point Likert scale ranging from 0 (pain does not interfere with sleep) to 10 (pain completely interferes with sleep) during past 24-hour period. Higher score indicates a greater level of sleep disturbance. Self-assessment performed daily on awakening prior to taking study medication. |
Baseline and Week 6 |
|
Secondary |
Change From Baseline in Sleep Interference Score for Fibromyalgia in ITT Population at Week 6 |
DSIS: participant rated 11-point Likert scale ranging from 0 (pain does not interfere with sleep) to 10 (pain completely interferes with sleep) during past 24-hour period. Higher score indicates a greater level of sleep disturbance. Self-assessment performed daily on awakening prior to taking study medication. |
Baseline and Week 6 |
|
Secondary |
Change From Baseline in Sleep Interference Score for Fibromyalgia in PP Population at Week 6 |
DSIS: participant rated 11-point Likert scale ranging from 0 (pain does not interfere with sleep) to 10 (pain completely interferes with sleep) during past 24-hour period. Higher score indicates a greater level of sleep disturbance. Self-assessment performed daily on awakening prior to taking study medication. |
Baseline and Week 6 |
|
Secondary |
Number of Participants With Clinician's Global Impression of Change (CGIC) Scale for NeP in ITT Population |
CGIC: 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Change is defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse), 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|
Secondary |
Number of Participants With CGIC Scale for NeP in PP Population |
CGIC: 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Change is defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse), 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|
Secondary |
Number of Participants With Patient's Global Impression of Change (PGIC) Scale for NeP in ITT Population |
PGIC was defined as participant rated instrument to measure participant's change in overall status on a 7-point scale; range from 1 (very much improved) to 7 (very much worse). Change was defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse) , 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|
Secondary |
Number of Participants With PGIC Scale for NeP in PP Population |
PGIC was defined as participant rated instrument to measure participant's change in overall status on a 7-point scale; range from 1 (very much improved) to 7 (very much worse). Change was defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse) , 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|
Secondary |
Number of Participants With CGIC Scale for Fibromyalgia in ITT Population |
CGIC: 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Change was defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse), 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|
Secondary |
Number of Participants With CGIC Scale for Fibromyalgia in PP Population |
CGIC: 7-point clinician rated scale ranging from 1 (very much improved) to 7 (very much worse). Change was defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse), 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|
Secondary |
Number of Participants With PGIC Scale for Fibromyalgia in ITT Population |
PGIC was defined as participant rated instrument to measure participant's change in overall status on a 7-point scale; range from 1 (very much improved) to 7 (very much worse). Change is defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse) , 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|
Secondary |
Number of Participants With PGIC Scale for Fibromyalgia in PP Population |
PGIC was defined as participant rated instrument to measure participant's change in overall status on a 7-point scale; range from 1 (very much improved) to 7 (very much worse). Change is defined as a score of 1 (very much improved), 2 (much improved), 3 (a little improved), 4 (no change), 5 (a little worse) , 6 (much worse) or 7 (very much worse) on the scale. Higher score is equal to more affected. |
Week 6 |
|